Macrocyclic kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S250000, C540S456000

Reexamination Certificate

active

10980740

ABSTRACT:
Compounds having the formulaare useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 2003/0069284 (2003-04-01), Keegan et al.
patent: 0 792 875 (1997-09-01), None
patent: 2004/026881 (2004-04-01), None
Tyle, “Iontophoretic devices for drug delivery,” Pharmaceutical Research 3(6):318-326 (1986).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Macrocyclic kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrocyclic kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3762531

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.